Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Apply
N-803 & ETBX-071
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step